BIOLASE (NASDAQ:BIOL) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL) in a research note published on Friday morning. The brokerage issued a sell rating on the medical technology company’s stock.

A number of other research analysts also recently issued reports on the company. Maxim Group downgraded BIOLASE from a strong-buy rating to a hold rating in a research note on Friday, May 24th. Benchmark restated a speculative buy rating and set a $0.40 price target on shares of BIOLASE in a research report on Monday, August 12th.

BIOLASE Price Performance

Shares of BIOL stock opened at $0.05 on Friday. The firm has a 50-day moving average of $0.08 and a 200-day moving average of $0.15. BIOLASE has a one year low of $0.04 and a one year high of $6.00. The company has a market cap of $1.57 million, a P/E ratio of 0.00 and a beta of 0.71.

BIOLASE (NASDAQ:BIOL) last posted its quarterly earnings data on Thursday, August 8th. The medical technology company reported ($0.08) EPS for the quarter. The firm had revenue of $11.56 million during the quarter. BIOLASE had a negative net margin of 43.56% and a negative return on equity of 1,782.73%.

Institutional Investors Weigh In On BIOLASE

An institutional investor recently raised its position in BIOLASE stock. Virtu Financial LLC raised its position in shares of BIOLASE, Inc. (NASDAQ:BIOL) by 1,068.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 143,537 shares of the medical technology company’s stock after purchasing an additional 131,248 shares during the period. Virtu Financial LLC owned 0.43% of BIOLASE worth $27,000 as of its most recent filing with the Securities and Exchange Commission. 8.79% of the stock is currently owned by institutional investors and hedge funds.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.